Kuo HL

No ORCID on file · 1 paper in corpus

2025

KELIM score and BRCA status are unreliable to predict the completeness of cytoreduction during interval debulking surgery with hyperthermic intraperitoneal chemotherapy for ovarian cancers.

Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2025.05.015

ObjectiveThe gold standard for treating primary advanced ovarian, primary peritoneal, and fallopian tubal cancers (OC) is optimal debulking surgery plus adjuvant chemotherapy. Neoadjuvant chemotherapy followed by optimal interval debulking …